2014 Q4 Form 10-Q Financial Statement

#000123252414000137 Filed on November 04, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $328.1M $306.6M $232.2M
YoY Change 39.18% 32.06% 32.27%
Cost Of Revenue $28.80M $27.00M $24.30M
YoY Change 12.5% 11.11% -25.46%
Gross Profit $295.4M $277.4M $206.1M
YoY Change 41.92% 34.58% 45.68%
Gross Profit Margin 90.03% 90.49% 88.79%
Selling, General & Admin $103.8M $93.50M $74.97M
YoY Change 28.47% 24.72% 23.05%
% of Gross Profit 35.14% 33.7% 36.37%
Research & Development $600.0K $22.42M $11.83M
YoY Change -95.65% 89.61% 70.9%
% of Gross Profit 0.2% 8.08% 5.74%
Depreciation & Amortization $34.10M $32.40M $20.40M
YoY Change 59.35% 58.82% -7.69%
% of Gross Profit 11.54% 11.68% 9.9%
Operating Expenses $600.0K $248.5M $131.6M
YoY Change -99.48% 88.87% 9.47%
Operating Profit $294.8M $58.04M $100.6M
YoY Change 217.17% -42.29% 81.84%
Interest Expense -$14.70M -$14.53M -$6.202M
YoY Change 107.04% 134.28% -19.97%
% of Operating Profit -4.99% -25.04% -6.17%
Other Income/Expense, Net
YoY Change
Pretax Income $115.2M $49.99M $93.74M
YoY Change 31.81% -46.67% 101.81%
Income Tax $33.60M $24.22M $18.34M
% Of Pretax Income 29.17% 48.45% 19.56%
Net Earnings $81.61M $25.77M $75.41M
YoY Change 47.6% -65.83% 127.07%
Net Earnings / Revenue 24.87% 8.4% 32.48%
Basic Earnings Per Share $1.35 $0.43 $1.30
Diluted Earnings Per Share $1.30 $0.41 $1.23
COMMON SHARES
Basic Shares Outstanding 60.49M shares 60.31M shares 58.22M shares
Diluted Shares Outstanding 62.68M shares 61.52M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $684.0M $575.0M $588.5M
YoY Change 7.46% -2.29% 210.06%
Cash & Equivalents $684.0M $575.0M $588.5M
Short-Term Investments $684.0M $575.0M $588.0M
Other Short-Term Assets $21.32M $18.36M $18.55M
YoY Change -37.0% -1.02% 86.59%
Inventory $30.04M $37.61M $24.87M
Prepaid Expenses $12.80M $24.21M $19.35M
Receivables $186.4M $187.6M $113.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.016B $878.5M $810.1M
YoY Change 17.49% 8.45% 110.4%
LONG-TERM ASSETS
Property, Plant & Equipment $58.36M $44.21M $12.06M
YoY Change 309.68% 266.54% 80.78%
Goodwill $702.7M $724.4M $446.8M
YoY Change 56.0% 62.12% 2.1%
Intangibles $1.437B $1.551B $823.7M
YoY Change 76.94% 88.25% -6.07%
Long-Term Investments
YoY Change
Other Assets $15.93M $13.48M $6.391M
YoY Change 118.11% 110.95% -68.68%
Total Long-Term Assets $2.323B $2.469B $1.375B
YoY Change 69.13% 79.51% 2.52%
TOTAL ASSETS
Total Short-Term Assets $1.016B $878.5M $810.1M
Total Long-Term Assets $2.323B $2.469B $1.375B
Total Assets $3.339B $3.348B $2.185B
YoY Change 49.18% 53.17% 26.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.13M $29.67M $22.43M
YoY Change 19.62% 32.26% 9.25%
Accrued Expenses $164.1M $161.5M $106.4M
YoY Change 37.06% 51.78% -13.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.428M $9.444M $5.572M
YoY Change 69.2% 69.49% -79.15%
Total Short-Term Liabilities $216.8M $223.7M $203.4M
YoY Change 6.26% 10.02% 13.88%
LONG-TERM LIABILITIES
Long-Term Debt $1.333B $1.331B $545.6M
YoY Change 144.85% 144.03% 25.24%
Other Long-Term Liabilities $38.39M $33.60M $16.75M
YoY Change 91.58% 100.61% 674.97%
Total Long-Term Liabilities $1.371B $1.365B $562.3M
YoY Change 142.96% 142.74% 28.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $216.8M $223.7M $203.4M
Total Long-Term Liabilities $1.371B $1.365B $562.3M
Total Liabilities $1.588B $1.589B $765.7M
YoY Change 106.67% 107.49% 24.22%
SHAREHOLDERS EQUITY
Retained Earnings $34.70M -$34.67M -$2.674M
YoY Change 87.27% 1196.41% -98.98%
Common Stock $1.458B $1.432B $1.201B
YoY Change 19.48% 19.19% 5.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.371B $1.341B $1.244B
YoY Change
Total Liabilities & Shareholders Equity $3.339B $3.348B $2.185B
YoY Change 49.18% 53.17% 26.57%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $81.61M $25.77M $75.41M
YoY Change 47.6% -65.83% 127.07%
Depreciation, Depletion And Amortization $34.10M $32.40M $20.40M
YoY Change 59.35% 58.82% -7.69%
Cash From Operating Activities $134.3M $129.7M $130.8M
YoY Change 69.57% -0.84% 196.6%
INVESTING ACTIVITIES
Capital Expenditures -$14.20M -$83.10M -$3.200M
YoY Change 358.06% 2496.88% -13.51%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$14.10M -$83.20M -$3.200M
YoY Change 354.84% 2500.0% -15.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.50M 263.3M -45.70M
YoY Change -63.67% -676.15% 730.91%
NET CHANGE
Cash From Operating Activities 134.3M 129.7M 130.8M
Cash From Investing Activities -14.10M -83.20M -3.200M
Cash From Financing Activities -10.50M 263.3M -45.70M
Net Change In Cash 109.7M 309.8M 81.90M
YoY Change 132.42% 278.27% 135.34%
FREE CASH FLOW
Cash From Operating Activities $134.3M $129.7M $130.8M
Capital Expenditures -$14.20M -$83.10M -$3.200M
Free Cash Flow $148.5M $212.8M $134.0M
YoY Change 80.44% 58.81% 180.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21005000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
29671000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
187604000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124805000 USD
CY2014Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
48437000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
31829000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119718000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
161476000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5225000 USD
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4396000 USD
CY2014Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9738000 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6082000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13763000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10613000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56153000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57133000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1431790000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1220317000 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
126862000 USD
us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
17306000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50919000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
4075000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50618000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11876000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32139000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18251000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12782000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
8374000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
22289000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
35447000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58518000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94607000 USD
CY2013Q4 us-gaap Assets
Assets
2238221000 USD
CY2014Q3 us-gaap Assets
Assets
3347536000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
878520000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
864617000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
636504000 USD
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
575040000 USD
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
575040000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
636504000 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
100811000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-12900000 USD
CY2014Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
8941000 USD
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7960000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575040000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
636504000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588462000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
387196000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-61464000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
201266000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
6000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
174595000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
100811000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91313000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-136511000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1067000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-137578000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
174595000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-91321000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.76
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and marketable securities. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and marketable securities and issuers of investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the United States, and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse effect on our financial position, liquidity or results of operations. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">86%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts Specialty Distribution Services, Inc. and its affiliate CuraScript, Inc., or Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">62%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Accredo Health Group, Inc., or Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Idis Limited, which accounted for </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160; As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">85%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">69%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">9%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We depend on single source suppliers and manufacturers for each of our products, product candidates and their active pharmaceutical ingredients.</font></div></div>
CY2014Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
24247000 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4388000 USD
CY2014Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1474552000 USD
CY2013Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
14605000 USD
CY2014Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
35068000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36246000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17962000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5718000 USD
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4784000 USD
CY2014Q3 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
35696000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
33613000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
101249000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
74597000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
6259000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
6259000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
413460000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
168497000 USD
us-gaap Depreciation
Depreciation
5037000 USD
us-gaap Depreciation
Depreciation
2065000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.30
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
164000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2807000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.669
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.485
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270
CY2013Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3502000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9850000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
15171000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5469000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4075000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
82000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4075000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
82000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
181552000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
253295000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
839926000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
29440000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
105310000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
108568000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
108659000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
113009000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1558207000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
959689000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1304912000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
778137000 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1897000 USD
CY2014Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2254000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-47000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3749000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q3 us-gaap Goodwill
Goodwill
724388000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
450456000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
308642000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-34710000 USD
CY2014Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2013Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
32806000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
220593000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49989000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36313000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93744000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18335000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60598000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24221000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59574000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6670000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-33865000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50690000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37649000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-19086000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
19003000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1562000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
19468000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-918000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-776000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3445000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10184000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3421000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5775000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
12910000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
10125000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4262000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11300000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1508000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
87000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1450000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1587000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1852000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2288000 shares
CY2014Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1803919000 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
993948000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1550624000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
812396000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-20743000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-36035000 USD
CY2013Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6202000 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14530000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14862000 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20455000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
37612000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
28669000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3177000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3506000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10301000 USD
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13980000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4587000 USD
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
7192000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2238221000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3347536000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
223743000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
204028000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
549976000 USD
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
1340784000 USD
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9444000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5572000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
575275000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2437000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
868490000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9455000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
9450000 USD
CY2014Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9445000 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1331340000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
544404000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
417000 USD
CY2014Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
7111000 USD
CY2014Q3 us-gaap Minority Interest
MinorityInterest
90000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
0 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
136950000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
721474000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4867000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13162000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1053475000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
273344000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
209397000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
75409000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23225000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
25766000 USD
us-gaap Net Income Loss
NetIncomeLoss
161019000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1060000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
136578000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Expenses
OperatingExpenses
779065000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
131600000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
248548000 USD
us-gaap Operating Expenses
OperatingExpenses
390836000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
65668000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
100560000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
58036000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
245813000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
26672000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1334000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4533000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7467000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
9989000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
772000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2577000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12100000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19850000 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
18362000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
33843000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7304000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13482000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-113293000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-117089000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
25402000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-113293000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13576000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-113293000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13576000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-117089000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25402000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20040000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33596000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-221000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4435000 USD
CY2014Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6483000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-728000 USD
CY2013Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-614000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6680000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
35100000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29973000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
102397000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17306000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5303000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
136950000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
828676000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1300000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6874000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22799000 USD
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24206000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7183000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1195366000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
553425000 USD
us-gaap Profit Loss
ProfitLoss
161019000 USD
CY2014Q3 us-gaap Profit Loss
ProfitLoss
25768000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
75409000 USD
us-gaap Profit Loss
ProfitLoss
-24285000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24859000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57968000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44205000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14246000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
300000000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
464517000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
7090000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
202000000 USD
CY2014Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
75000000 USD
CY2013Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
988000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
4988000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11826000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60622000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27823000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22423000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34666000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18532000 USD
CY2013Q3 us-gaap Revenues
Revenues
232160000 USD
CY2014Q3 us-gaap Revenues
Revenues
306584000 USD
us-gaap Revenues
Revenues
844733000 USD
us-gaap Revenues
Revenues
636649000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
631602000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
230386000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
838493000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
304407000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
300420000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
223004000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74970000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93501000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
50618000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
32139000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
29973000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1295534000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
1340523000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1295534000 USD
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1340613000 USD
CY2014Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
15755000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
336000 USD
CY2014Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
25700000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61532000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59457000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62680000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61519000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59457000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60305000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58217000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58437000 shares
CY2014Q3 jazz Accrued Construction In Progress
AccruedConstructionInProgress
3117000 USD
CY2013Q4 jazz Accrued Construction In Progress
AccruedConstructionInProgress
450000 USD
CY2014Q3 jazz Accrued Interest
AccruedInterest
7940000 USD
CY2013Q4 jazz Accrued Interest
AccruedInterest
4150000 USD
CY2013Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
38772000 USD
CY2014Q3 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
52861000 USD
CY2013Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2014Q3 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2014Q3 jazz Computer Equipment Gross
ComputerEquipmentGross
6609000 USD
CY2013Q4 jazz Computer Equipment Gross
ComputerEquipmentGross
5610000 USD
CY2014Q3 jazz Contingent Consideration Current
ContingentConsiderationCurrent
0 USD
CY2013Q4 jazz Contingent Consideration Current
ContingentConsiderationCurrent
50000000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
88610000 USD
CY2014Q3 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
26994000 USD
CY2013Q3 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
24252000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
76503000 USD
CY2013Q4 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.85
CY2014Q3 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.86
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
10477000 USD
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
3143000 USD
CY2013Q3 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-3749000 USD
CY2014Q3 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Increase Decreasein Contingent Consideration
IncreaseDecreaseinContingentConsideration
-14900000 USD
jazz Increase Decreasein Contingent Consideration
IncreaseDecreaseinContingentConsideration
0 USD
CY2013Q3 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
19564000 USD
CY2014Q3 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
30630000 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
58518000 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
94607000 USD
CY2013Q4 jazz Inventory Step Up Value
InventoryStepUpValue
200000 USD
CY2013Q4 jazz Landand Buildings Gross
LandandBuildingsGross
0 USD
CY2014Q3 jazz Landand Buildings Gross
LandandBuildingsGross
1614000 USD
CY2014Q3 jazz Modified Effective Income Tax Rate Continuing Operations
ModifiedEffectiveIncomeTaxRateContinuingOperations
0.194
jazz Modified Effective Income Tax Rate Continuing Operations
ModifiedEffectiveIncomeTaxRateContinuingOperations
0.254
CY2014Q3 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2013Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2014Q3 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
CY2013Q4 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
jazz Number Of Radiopharmaceutical Products
NumberOfRadiopharmaceuticalProducts
2 product
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
202000000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
4988000 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
48452000 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
23577000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1758000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
2873000 USD
CY2014Q3 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
2177000 USD
CY2013Q3 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
1774000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
5047000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
6240000 USD
CY2013Q4 jazz Sales Return Reserve
SalesReturnReserve
21110000 USD
CY2014Q3 jazz Sales Return Reserve
SalesReturnReserve
15137000 USD
jazz Stock Issued During Period Employee Plansand Warrants Amount
StockIssuedDuringPeriodEmployeePlansandWarrantsAmount
48452000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60491676 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
dei Trading Symbol
TradingSymbol
JAZZ

Files In Submission

Name View Source Status
0001232524-14-000137-index-headers.html Edgar Link pending
0001232524-14-000137-index.html Edgar Link pending
0001232524-14-000137.txt Edgar Link pending
0001232524-14-000137-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jazz-20140930.xml Edgar Link completed
jazz-20140930.xsd Edgar Link pending
jazz-20140930_cal.xml Edgar Link unprocessable
jazz-20140930_def.xml Edgar Link unprocessable
jazz-20140930_lab.xml Edgar Link unprocessable
jazz-20140930_pre.xml Edgar Link unprocessable
jazz2014q3doc.htm Edgar Link pending
jazzq32014ex101.htm Edgar Link pending
jazzq32014ex102.htm Edgar Link pending
jazzq32014ex103.htm Edgar Link pending
jazzq32014ex311.htm Edgar Link pending
jazzq32014ex312.htm Edgar Link pending
jazzq32014ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending